Literature DB >> 6719125

Perinatal dopamine-related drugs demasculinize rats.

E M Hull, J K Nishita, D Bitran, S Dalterio.   

Abstract

Administration of haloperidol, a common neuroleptic, to pregnant or lactating rats impaired the masculine sex behavior of their male offspring. Prenatal haloperidol did not affect testosterone concentrations in fetuses. Maternal administration of apomorphine, a dopamine agonist, and of alpha-methyl-p-tyrosine, an inhibitor of dopamine synthesis, also demasculinized male offspring. In both experiments other behaviors and developmental milestones were unaffected. Perinatal haloperidol, apomorphine, and alpha-methyl-p-tyrosine did not lower testosterone in adulthood. These drugs may act directly on neurons that control masculine behavior without lowering testosterone prenatally or in adulthood.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6719125     DOI: 10.1126/science.6719125

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Dopamine activates masculine sexual behavior independent of the estrogen receptor alpha.

Authors:  S R Wersinger; E F Rissman
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

2.  Sexual function in adult male rats after prenatal modulation of the cholinergic system.

Authors:  A A Bairamov; A O Poletaeva; S N Proshin; O M Efremov; N S Sapronov
Journal:  Neurosci Behav Physiol       Date:  2009-05-12

Review 3.  Brain sex differences and the organisation of juvenile social play behaviour.

Authors:  A P Auger; K M Olesen
Journal:  J Neuroendocrinol       Date:  2009-06       Impact factor: 3.627

Review 4.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis.

Authors:  Eline M P Poels; Lisanne Schrijver; Astrid M Kamperman; Manon H J Hillegers; Witte J G Hoogendijk; Steven A Kushner; Sabine J Roza
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-06-11       Impact factor: 4.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.